Predilife (XPAR:ALPRE) Change In Inventory : €0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Predilife Change In Inventory?

Predilife's change in inventory for the quarter that ended in Jun. 2023 was €0.00 Mil. It means Predilife's inventory stayed the same from Dec. 2022 to Jun. 2023 .

Predilife's change in inventory for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means Predilife's inventory stayed the same from Dec. 2021 to Dec. 2022 .

Predilife's Total Inventories for the quarter that ended in Jun. 2023 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Predilife's Days Inventory for the quarter that ended in Jun. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Predilife's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.00.

Predilife Change In Inventory Historical Data

The historical data trend for Predilife's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predilife Change In Inventory Chart

Predilife Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

Predilife Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial									-	-	-	-	-

Predilife Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Predilife (XPAR:ALPRE) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Predilife's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0.936	*	365 / 2
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Predilife's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.936	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Predilife's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.165
	=	0.00

Predilife Change In Inventory Related Terms

Thank you for viewing the detailed overview of Predilife's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Predilife (XPAR:ALPRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Predilife SA (XPAR:ALPRE) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

114 rue Edouard Vaillant Espace Maurice Tubiana, Villejuif, Paris, FRA, 94800

Website

https://www.predilife.com

Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.

Predilife (XPAR:ALPRE) Headlines

No Headlines